Clinical trials
Terminated Phase 1 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Celldex Therapeutics | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| Astellas Pharma Inc | 1 |
| Aurigene Discovery Technologies Limited | 1 |
| AvenCell Europe GmbH | 1 |
| Bristol-Myers Squibb | 1 |
| Cytheris SA | 1 |
| Harry Drabkin | 1 |
| Inhibrx Biosciences, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 22 |
| Carcinoma, Renal Cell | 13 |
| Lung Neoplasms | 6 |
| Melanoma | 6 |
| Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Head and Neck Neoplasms | 4 |
| Kidney Diseases | 4 |
| Liver Neoplasms | 4 |
| Sarcoma | 4 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.